TORONTO, June 03, 2021 (GLOBE NEWSWIRE) — Field Trip Health Ltd. (CSE: FTRP; FTRP.WT; OTCQX: FTRPF) (“Field Trip”), a leader in the development and delivery of psychedelic therapies, is pleased to announce that its common shares will commence trading on the Toronto Stock Exchange (“TSX”) under the ticker symbol “FTRP” and its warrants will trade under the symbol “FTRP.WT” at the opening of the…


Previous articleCOMPASS Pathways and Kings College London publish cognition results from COMP360 psilocybin study in healthy volunteers
Next articleOp-ed: UK Public Support Psilocybin Research & Rescheduling Despite Government Stance